Trump Takes Major Action to Reduce Drug Costs for Americans
President Donald Trump signed an executive order on Monday to reduce drug prices in America to rates similar to what those in other nations pay.

President Donald Trump signed an executive order on Monday to reduce drug prices in America to rates similar to what those in other nations pay.
“There has never been a president more willing to stand up to the oligarchs” than President Donald Trump, Health and Human Services Secretary Robert F. Kennedy Jr. said during a press conference Monday, where Trump signed an executive order to reduce the cost of prescription medications.
While the abortion pill is touted as “safe and effective,” new data suggests complications are 22 times higher than previously reported.
Pharmaceutical company Novartis announced plans to build seven facilities in the United States and expand others in a $23 billion investment over five years on the heels of President Donald Trump’s announcement of forthcoming tariffs on imported drugs.
What do Big Pharma ads on TV and Diet Coke have in common? Both are targets of Robert F. Kennedy, Jr., the new head of the Health and Human Services department.
Pharmaceutical companies advertise to “have influence and control over media outlets,” Dr. Drew Pinsky, host of the long-running Loveline radio show, said during an appearance on Breitbart News Daily, discussing the overarching theme of making America healthy again.
The U.S needs a “sledgehammer” like Robert F. Kennedy Jr. to unravel the bureaucracy in the health system, Dr. Drew Pinsky said during an appearance on Breitbart News Daily.
Vice President Kamala Harris claimed that President Joe Biden and her administration “finally” capped the cost of insulin for seniors.
Drugs developed with the assistance of public funding would be vulnerable to government price controls and patent seizures if Biden succeeds in implementing an unprecedented expansion of an authority originally created in 1980.
Former New Jersey Gov. and GOP presidential candidate Chris Christie became a registered lobbyist after leaving public service.
Missouri Attorney General Andrew Bailey issued an emergency regulation on transgender medical interventions for minors, telling Breitbart News, “We are on offense” and leaving “no stone unturned” in the defense of children.
Danish pharmaceutical company Novo Nordisk has announced that it will lower the price of some of its insulin products in the United States by up to 75 percent, effective January 1, 2024.
The FTC has reportedly called on “Pharma Bro” Martin Shkreli to be held in contempt of court for allegedly disobeying terms of a recent investigation into his business dealings.
Republican J.D. Vance says “pharmaceutical blood money” is fueling Rep. Tim Ryan’s (D-OH) Senate campaign in Ohio.
The Pediatric Endocrine Society (PES) has received over $125k between 2017 and 2021 from AbbVie, a pharmaceutical company that is under investigation in Texas and produces a drug commonly used as a puberty blocker.
News media coverage of COVID-19 information is corrupted due to conflicts of interest with pharmaceutical companies, James O’Keefe said.
House Oversight Committee Ranking Member James Comer (R-KY) told Breitbart News in an exclusive comment Tuesday that Democrats’ Build Back Better Act big pharmaceutical carveouts puts Americans last by driving up prescription drugs.
A drug pricing provision in the $3.5 trillion reconciliation package currently making its way through Congress could derail the entire package, and Rep. Andy Kim (D-NJ) is one of two New Jersey Democrats facing pressure from within the Garden State to break with the party and oppose the provision.
“Pfizer and others even decided to not assess the results of their vaccine, in other words, not come out with a vaccine, until just after the election,” Trump said.
“Big pharma doesn’t mean anything to me other than we want them to do a great job,” Trump said during a press conference. “We want them to get their vaccines.”
Last month Wikipedia’s Arbitration Committee, often likened to a Supreme Court, sanctioned a member of the Board of Trustees for the Wikimedia Foundation, which owns the site. The board member, Dr. James Heilman, was barred from edits related to drug pricing in medical articles following disputes with other Wikipedia editors about the propriety of such edits. Heilman, an ER doctor, argued for the inclusion of drug prices in articles and accused the American drug industry of seeking to conceal such details.
Drugs can be manufactured in America more quickly, efficiently, and with better quality control than in China, said Rosemary Gibson, senior adviser at the Hastings Center and author of China Rx: Exposing the Risks of America’s Dependence on China for Medicine.
Restoring American generic drug manufacturing would create “hundreds of thousands of good-paying STEM jobs,” explained Rosemary Gibson, author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine,” on Tuesday’s edition of SiriusXM’s Breitbart News Tonight with host Rebecca Mansour.
A reshoring of pharmaceutical production is needed now to respond to the coronavirus more than ever.
America’s “mainstream media” often act as apologists for China’s Communist Party, noted Tom Cotton while discussing the coronavirus outbreak.
Sen. Marsha Blackburn (R-TN) called on the United States to rebuild its domestic pharmaceutical manufacturing capacity in order to end China’s monopoly on the drugs Americans rely on.
Waltz will introduce a bill this week to lessen America’s dependence on Chinese pharmaceuticals and reduce the risk to its supply chains.
The coronavirus outbreak exposes the need to protect domestic medicine and medical supplies manufacturing as a “strategic national asset,” explains “China Rx” author Rosemary Gibson.
An article in China’s state-run Xinhua news service last week threatened to impose restrictions on medical exports so the United States will be “plunged into the mighty sea of coronavirus.”
Pharmaceutical companies have been punching bags for Democratic presidential candidates throughout the 2020 primary — but now that they are needed to produce a vaccine for coronavirus, attacking them doesn’t look so good.
The coronavirus outbreak has exposed the United States’ dangerous dependence on China for pharmaceutical and medical supplies, including an estimated 97 percent of all antibiotics and 80 percent of the active pharmaceutical ingredients needed to produce drugs in the United States.
During the CNN and New York Times Democrat debate on Tuesday night, Sen. Elizabeth Warren (D-MA) suggested that politicians cannot pretend to take on Big Tech and big pharmaceutical corporations after taking their donations — something Sen. Kamala Harris (D-CA) has continued to do throughout her run for president.
The White House will put measures in place as soon as this summer to require further transparency from drug advertisers.
The Rochester Drug Co-operative and its former CEO Laurence Doud III were charged on Tuesday with conspiring to defraud the Drug Enforcement Administration (DEA) — and the rest of the country.
A crowd of angry Chinese parents gathered outside the Licheng Health Center in Jiangsu province on Friday and demanded answers about the seemingly bottomless vaccine scandal that saw thousands of children receiving substandard or expired doses of vaccine.
As the Trump administration pushes for drug price transparency, the pharmaceutical industry is already trying to subvert the coming changes.
The simple truth of the opioid crisis is that prescription drugs have been blamed for a deadly crisis that is far more attributable to street drugs smuggled across the porous U.S. border.
The grim saga of Changsheng Biotechnology continues to roil China with news that the embattled pharmaceutical firm produced a second huge batch of substandard vaccine doses for children, doubling the number of doses originally estimated.
A study by St. Michael’s Hospital of Toronto published in June found that one in five deaths among young adults in the United States is now related to opioid drugs.
President Donald Trump’s campaign promises already have convinced drug companies to lower prices and increase transparency.